ArticleBMC cardiovascular disorders2026
Visit-to-visit variability and longitudinal change of the triglyceride-glucose index are associated with early carotid plaque progression.
Article in BMC cardiovascular disorders, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundThe triglyceride-glucose (TyG) index is a surrogate marker of insulin resistance, but the clinical relevance of its longitudinal dynamics remains unclear. This study aimed to evaluate whether visit-to-visit variability in TyG (TyG-CV) and longitudinal change in TyG (TyG-Slope) were associated with early carotid plaque progression and improved risk prediction beyond conventional factors and mean TyG.
methodsIn this single-centre retrospective longitudinal cohort, 1,519 adults aged 18-65 years who completed three annual examinations from 2023 to 2025 were included. Fasting triglycerides and fasting plasma glucose were measured from overnight fasting venous blood samples using standardized laboratory assays, and the TyG index was calculated at each visit. Carotid plaque and plaque area were assessed by standardized carotid ultrasonography. TyG-CV was calculated as SD/mean × 100%, and TyG-Slope was estimated as the annualized linear change in TyG across the three examinations. Plaque progression was defined as incident plaque in 2025 or an increase in total plaque area of ≥ 0.05 cm² from 2023 to 2025.
resultsPlaque progression occurred in 384 participants (25.3%) and was more frequent in higher TyG-CV quartiles. In the fully adjusted model, both TyG-CV and TyG-Slope were independently associated with plaque progression (per 1-SD increase: OR 1.28, 95% CI 1.13-1.45; and OR 1.26, 95% CI 1.12-1.42, respectively), whereas mean TyG was not. Restricted cubic spline analyses showed significant overall associations for both dynamic metrics, without statistically significant evidence of non-linearity. Adding spline-modelled TyG-CV or TyG-Slope was associated with modest improvements in discrimination and reclassification in internal model evaluation, while the model including both dynamic metrics achieved the highest predictive performance among the evaluated models.
conclusionsTyG-CV and TyG-Slope were independently associated with early carotid plaque progression and provided incremental predictive information beyond conventional factors and mean TyG in this single-centre health-screening cohort. External validation is needed before clinical application.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.